U.S. stock anomaly | Eli Lilly (LLY.US) rises 3.8%, Wall Street major banks maintain its "buy" rating
According to the Wisdom Finance app, on Monday, shares of Eli Lilly (LLY.US) rose, with the stock up 3.8% to $649.66 at the time of writing. On the news front, Deutsche Bank analyst James Shin maintained a "buy" rating on Eli Lilly but lowered the target price to $900. Analysts Akash Tewari from Credit Suisse, Terence Flynn from Morgan Stanley, Chris Schott from JPMorgan Chase, Geoff Meacham from Citigroup, and Srikripa Devarakonda from Truist Financial also maintained a "buy" rating on the stock.
Latest